Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Codexis Inc 200 PENOBSCOT DRIVE REDWOOD CITY CA 94063 USA

www.codexis.com P: 650-421-8100

Description:

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis' proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.

Key Statistics

Overview:

Market Capitalization, $K 232,841
Enterprise Value, $K 167,211
Shares Outstanding, K 70,558
Annual Sales, $ 70,140 K
Annual Net Income, $ -76,240 K
Last Quarter Sales, $ 17,070 K
Last Quarter Net Income, $ -11,510 K
EBIT, $ -56,300 K
EBITDA, $ -46,380 K
60-Month Beta 2.12
% of Insider Shareholders 2.10%
% of Institutional Shareholders 78.54%
Float, K 69,076
% Float 97.90%
Short Volume Ratio 0.44

Growth:

1-Year Return 3.80%
3-Year Return -84.25%
5-Year Return -82.23%
5-Year Revenue Growth 15.76%
5-Year Earnings Growth -252.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 05/02/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -0.57
EPS Growth vs. Prev Qtr -900.00%
EPS Growth vs. Prev Year 52.94%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CDXS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.76%
Return-on-Assets % -24.61%
Profit Margin % -108.70%
Debt/Equity 0.35
Price/Sales 3.46
Price/Cash Flow N/A
Price/Book 3.06
Book Value/Share 1.12
Interest Coverage -0.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar